APA (7th ed.) Citation

Gürpınar, A., Esenkaya, M., Eraydin, B., Eser-Ozturk, H., & Süllü, Y. (2025). Long-Term Effectiveness and Safety of Weekly Adalimumab in Refractory Non-Infectious Uveitis. Ocular Immunology & Inflammation, 33(10), 2342. https://doi.org/10.1080/09273948.2025.2516826

Chicago Style (17th ed.) Citation

Gürpınar, Abdülcemal, Mertcan Esenkaya, Bilge Eraydin, Hilal Eser-Ozturk, and Yüksel Süllü. "Long-Term Effectiveness and Safety of Weekly Adalimumab in Refractory Non-Infectious Uveitis." Ocular Immunology & Inflammation 33, no. 10 (2025): 2342. https://doi.org/10.1080/09273948.2025.2516826.

MLA (9th ed.) Citation

Gürpınar, Abdülcemal, et al. "Long-Term Effectiveness and Safety of Weekly Adalimumab in Refractory Non-Infectious Uveitis." Ocular Immunology & Inflammation, vol. 33, no. 10, 2025, p. 2342, https://doi.org/10.1080/09273948.2025.2516826.